Compare Repligen Corporation Common Stock (RGEN) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs SoFi Technologies Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while SoFi Technologies Inc trades at $14 (market cap $19.68B). The key difference: SoFi Technologies Inc is the larger of the two by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and SoFi Technologies Inc for 60 Days on average.
| RGEN | SOFI | |
|---|---|---|
Market Cap | $11.14B | $19.68B |
Volume | 1,259,263 | 30,790,556 |
Sector | Health | Financials |
52-Week High | $194.57 | $32.21 |
52-Week Low | $102.87 | $14.22 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $11.02B | $19.83B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
SoFi Technologies stock trades at $14.22, down 6.63% with bearish technical signals. The company shows strong revenue growth from $2.6B in 2024 to $3.6B in 2025, with consistent earnings beats. However, negative operating cash flow and high P/E ratio of 31.1 present valuation concerns. Recent news highlights SoFi's stablecoin initiatives and record loan originations while the stock faces pressure from rising yields.
SoFi offers growth potential with expanding financial services but faces execution risks in a competitive fintech landscape. The stock trades at a discount to analyst consensus target of $21.08, though negative cash flow trends and market sensitivity to interest rates warrant caution. Investors should weigh strong fundamentals against technical weakness and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
